Nam Nhito

Nam Nhito is an experienced Investment Manager specializing in Life Sciences and Venture Capital at Brandenburg Kapital GmbH since October 2020. In addition to the current role, Nam serves on the boards of multiple companies, including Captain T Cell, Seqstant GmbH, smedo GmbH, Caterna, and PAM Theragnostics GmbH, and acts as a Board Observer for ThinkSono and Emperra GmbH E-Health Technologies. Prior experience includes a role as an Analyst in Strategy & New Business at Medicover and a Board Observer position at Pentracor GmbH. Nam's educational background includes Master's degrees in Industrial Engineering and Management and Pharmaceutical Bioprocess Engineering from TUM School of Management and Technical University of Munich, respectively, along with a Bachelor's degree in Bioprocess Engineering from the Technical University of Munich and research experience at UCL, Seoul National University, and Lund University.